Print Page  Close Window

News Release

Emergent BioSolutions to Hold Annual Meeting of Stockholders

ROCKVILLE, Md.--(BUSINESS WIRE)--June 11, 2007--Emergent BioSolutions Inc. (NYSE:EBS) announced today that it will hold its Annual Meeting of Stockholders on Thursday June 14, 2007 beginning at 10:00 am Eastern Time at the Hyatt Regency Bethesda, One Metro Center, 7400 Wisconsin Avenue, Bethesda, Maryland.

Interested parties may listen to the Annual Meeting via conference call by dialing either 1-866-700-0161 in the U.S. or +1-617-213-8832 outside the U.S. No Passcode is required for the live call. Interested parties may also access a webcast of the Annual Meeting by visiting the Emergent BioSolutions website at www.emergentbiosolutions.com. A replay of the webcast of the Annual Meeting will be available under the "Investors" section of the company's website until June 28, 2007.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission--to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and therapeutics that assist the body's immune system to prevent or treat disease. Our biodefense business focuses on immunobiotics for use against biological agents that are potential weapons of bioterrorism and biowarfare. Our marketed product, BioThrax(R) (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Our commercial business focuses on immunobiotics for use against infectious diseases and other medical conditions that have resulted in significant unmet or underserved public health needs. More information on the company is available at www.emergentbiosolutions.com.

CONTACT: Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Corporate Communications
301-795-1877
burrowsr@ebsi.com

SOURCE: Emergent BioSolutions Inc.